Democratizing molecular diagnostics: the GeneXpert(®) enterovirus assay

Area of Science:

• Molecular Diagnostics
• Infectious Disease
• Clinical Microbiology

Background:

• Acute meningitis diagnosis is challenging due to nonspecific symptoms.
• Enteroviral infections cause most meningitis cases but typically resolve with supportive care.
• Rapid identification of meningitis pathogens is crucial for effective treatment.

Purpose of the Study:

• Develop a rapid, automated polymerase chain reaction (PCR)-based test for enteroviral meningitis.
• Ensure the test is user-friendly for widespread hospital laboratory adoption.
• Maximize clinical impact through on-demand availability.

Main Methods:

• Developed a sensitive and specific GeneXpert assay for enteroviral RNA detection in cerebrospinal fluid.
• Automated nucleic acid purification, amplification, and detection within approximately 2 hours.
• Validated through preclinical and clinical studies.

Main Results:

• Achieved high sensitivity (97.1% preclinical, 98% clinical) and specificity (100% preclinical, 97.1% clinical).
• The test received FDA clearance in February 2006 as an aid in diagnosing viral meningitis.
• Demonstrated on-demand availability and operational simplicity.

Conclusions:

• Rapid molecular diagnostics for enterovirus improve clinical decision-making in meningitis management.
• The GeneXpert enterovirus assay offers on-demand testing and broad accessibility for hospital laboratories.
• Sophisticated diagnostic capabilities are now available beyond specialized reference labs.